HPLC + MS
Independently tested for identity and purity
NP-CJCND-02
Aug 17, 2026
98.96%
View Certificate of Analysis
CAS# 863288-34-0
Also Known As Mod GRF(1-29)
Class Synthetic GHRH Analogue
Form Lyophilized Powder
Receptor Target
Modification
Peptide Length
CJC-1295 No DAC (Mod GRF(1-29), CAS# 863288-34-0) is a synthetic 29-amino acid analogue of growth hormone-releasing hormone (GHRH) with binding activity at the GHRH receptor (GHRHR). Unlike the DAC-modified variant, this form lacks the Drug Affinity Complex modification, resulting in a distinct pharmacokinetic profile relevant to short-duration signalling studies. Supplied by NexPept as a lyophilized powder for in vitro laboratory research use. This compound has not been authorized by Health Canada for any therapeutic, clinical, or human use.
Molecular Profile
CAS#, sequence length, analytical data
CAS#, sequence length, analytical data
| Property | Value |
|---|---|
| CAS Number | 863288-34-0 |
| Common Name | Modified GRF(1-29) / Mod GRF 1-29 |
| Compound Class | Synthetic GHRH analogue — modified peptide fragment |
| Sequence Length | 29 amino acids |
| Receptor Target | GHRHR (Growth Hormone-Releasing Hormone Receptor) |
| DAC Modification | Absent — no Drug Affinity Complex |
| Physical Form | Lyophilized powder |
| Analytical Method | High-Performance Liquid Chromatography (HPLC) + Mass Spectrometry (MS) |
| Appearance | White to off-white lyophilized solid |
In Vitro Research Context
Receptor pharmacology — laboratory use only
Receptor pharmacology — laboratory use only
A G protein-coupled receptor (GPCR) expressed on somatotroph cells. CJC-1295 No DAC is studied for its binding activity at this receptor in the context of peptide–receptor interaction research and endocrine signalling pathway models.
CJC-1295 No DAC is studied in preclinical in vitro settings as a pharmacological tool for investigating GHRH receptor binding, short-duration signalling cascade models, and structure–function relationships within the GHRH peptide family. The absence of the DAC modification makes this variant particularly relevant for studies requiring differentiation between short- and long-acting GHRH analogues in controlled experimental models.
Research context: CJC-1295 No DAC is an investigational synthetic peptide studied in scientific research involving GHRHR signalling. It has not been authorized by Health Canada for human or veterinary use.
Available Formats
5mg — lyophilized powder
5mg — lyophilized powder
| Format | Net Quantity | Physical Form |
|---|---|---|
| CJC-1295 No DAC 5mg | 5 mg / vial | Lyophilized powder |
Sourced from a verified batch. Quantity for use should be determined based on your specific in vitro research protocol by qualified research personnel.
Laboratory Storage
Controlled storage conditions for lyophilized material
Controlled storage conditions for lyophilized material
Store sealed lyophilized material under controlled laboratory conditions in accordance with validated institutional SOPs and applicable technical documentation. Protect from light and moisture. Handling conditions should be established by qualified research personnel in accordance with the specific experimental protocol.
Note: No preparation, reconstitution, or administration instructions are provided. This compound is supplied for in vitro laboratory research use only. All handling must be conducted by qualified personnel following institutional safety protocols.
Research Literature
Scientific references & related resources
Scientific references & related resources
CJC-1295 No DAC Research Peptide Overview — NexPept compound overview and in vitro research context
PubMed — CJC-1295 / Modified GRF(1-29) — peer-reviewed scientific literature on this compound
Research Peptides in Canada — sourcing and research context for Canadian laboratories
What Are Research Peptides? — peptide classification and in vitro research context
This product is supplied exclusively for in vitro laboratory and non-clinical research use by qualified research personnel. It is not authorized by Health Canada for human or veterinary use. No therapeutic, clinical, or health claims are made.
This material must not be administered to humans or animals. No dosage, preparation, reconstitution, or administration instructions are provided or implied. All handling and use must be conducted by qualified personnel in accordance with applicable institutional policies and legal requirements.
Be the first to review “CJC-1295 no DAC 5mg”
Related products
Reviews
There are no reviews yet.